VALERIO THERAPEUTICS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1114 EUR | +1.27% |
|
-4.13% | -32.48% |
| 2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Chart calendar Valerio Therapeutics
ad742561063879c67df70fcc0a87.myoTUKkZJcHWk4Pk0AAqVZKA7iIc4EI-nysFwdf5iMY.7kVxZtNOF4-09fuBhXVMBaPO2nVMlg1Z3npVkKK82Lz6B0ICnEprl5LX5A~13c692b2d7258b7b13c97cd7ec3705aa
Upcoming events on Valerio Therapeutics
Past events on Valerio Therapeutics
| 2023-09-28 14:13 | Q2 2023 Earnings Release |
| 2023-06-06 08:00 | Annual General Meeting |
| 2023-04-24 14:11 | Q4 2022 Earnings Release |
| 2023-02-05 | Extraordinary Shareholders Meeting |
| 2022-09-13 13:30 | Interim 2022 Earnings Release |
| 2022-08-17 08:00 | Shareholders Meeting |
| 2022-06-15 08:30 | Annual General Meeting |
| 2022-05-11 | Shareholders Meeting |
| 2022-04-19 08:00 | Extraordinary Shareholders Meeting |
| 2022-04-12 09:00 | American Association of Cancer Research Meeting - Oral No. PO.ET04.02 |
| 2022-04-10 15:35 | American Association of Cancer Research Meeting - Oral No. MS.ET03.01 |
| 2022-04-07 | American Association of Cancer Research Meeting |
| 2022-04-06 | FY 2021 Earnings Release After hours |
| 2021-12-08 12:00 | European Association for Cancer Research and AstraZeneca - AsiDNA tackles Drug-tolerant persister ce |
| 2021-09-12 | H.C. Wainwright Global Investment Conference |
| 2021-07-29 12:30 | Interim 2021 Earnings Release |
| 2021-06-20 | Kepler Cheuvreux & Belfius Digital Life Science Days |
| 2021-06-10 | BIO International Conference |
| 2021-06-10 09:00 | Annual General Meeting |
| 2021-05-11 | Shareholders Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 6,13 3,35 82.9% | 4,29 3,30 29.97% | 1,78 1,69 5.21% | 4,06 0,00 - |
|
EBITDA Million EUR | Released Forecast Spread | -2,99 -7,20 58.53% | -9,12 -11,4 19.66% | 2,81 -5,10 155.13% | -4,68 -10,1 53.81% |
|
EBIT Million EUR | Released Forecast Spread | -15,6 -16,5 4.99% | -34,3 -11,9 -188.64% | 2,19 -5,77 138.01% | -5,14 -10,8 52.35% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -11,2 -16,5 32.24% | -36,1 -11,9 -202.98% | 1,85 -6,21 129.73% | -5,84 -10,8 45.94% |
|
Net income Million EUR | Released Forecast Spread | -9,40 -14,8 36.31% | -33,7 -11,9 -183.45% | 1,09 -5,33 120.45% | -5,94 -10,8 45% |
|
EPS EUR | Released Forecast Spread | -0,18 -0,29 37.93% | -0,55 -0,22 -150% | 0,01 -0,08 112.5% | -0,07 -0,14 50% |
| Announcement Date | 12/03/19 | 17/04/20 | 21/04/21 | 06/04/22 |
More events
Past sector events for Valerio Therapeutics
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVIO Stock
- Calendar Valerio Therapeutics
